logo-loader

NA Proactive news snapshot: NEO Battery Materials, Manganese X Energy, BioHarvest Sciences, Pathway Health, MySize UPDATE ...

Last updated: 15:36 30 Dec 2021 EST, First published: 10:00 30 Dec 2021 EST

Newspapers and laptop

NEO Battery Materials Ltd CEO Spencer Huh said that after a “historical year,” the company expects to build on its successes in 2022 as it advances its patented silicon anode active materials for electric vehicle lithium-ion batteries. Specifically, Huh said in a statement that the company in the New Year will move ahead with the commercialization and improvement of its Silicon Microparticle Anode Material Products (NBMSiDE) with the trademark pending approval through the Korean Intellectual Property Office. He said each of the three NBMSiDE products retains unique nanocoating materials and characteristics that enable the silicon microparticles to perform as an anode material.

Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) has noted that 2021 “was another year of significant growth” for the company, highlighted by the advancement of its Battery Hill manganese project located near Woodstock, New Brunswick. “The manganese metal price has increased 100% during the year and has performed very well among the minor metal sectors. Experts are predicting that starting next year there will be a shortage of high purity manganese,” said Martin Kepman, CEO of Manganese X in a year-end review. He added: “This shortage will continue and by 2030 present production will only be fifth of the projected demand. Manganese X Energy is poised to take advantage of this situation and to become a major supplier to North American EV and back-up energy storage requirements within the near future.” The company said that for 2022, it is planning to successfully complete the Battery Hill project PEA and fast track directly into pre-feasibility or feasibility study.

BioHarvest Sciences Inc shared the year-end shareholder partner letter from CEO Ilan Sobel, highlighting the milestones from 2021 and visions for 2022. “Our vision is to drive human utility value: making a fundamental and positive change to our consumer's overall health and wellness,” Sobel said. “2022 will be a year in which we not only open new doors as we further scale and commercialize our products, but also open minds to the significant potential that our platform technology has to drive this fundamental improvement in health and wellness on a global scale.” In 2022, the company said it will expand its existing programs. BioHarvest expects to be selling its first cannabis-related products in 2022 upon completion of its final scale-up phase and regulatory approvals. For its VINIA product -- which reduces the oxidation of LDL cholesterol -- the company is planning a step up in aggressive US marketing and will continue to push forward on the regulatory approval in the EU and UK. 

Pathway Health (TSX-V:PHC) Corp, one of the largest providers of out-of-hospital pain management services in Canada, announced the issuance of 1.30 million stock options to officers, employees, and consultants on December 28, 2021. Each option allows the holder to acquire a share in the company for $0.50 per share, said the company. “The stock options are valid between a three-to-five-year period from the date of grant,” added the firm. The company's stock option plan allows for the issuance of up to 10% of issued and outstanding share capital in the form of incentive stock options. As a result of this grant, the company has 5.50 million stock options issued, representing 6% of the issued and outstanding share capital. The Toronto-based company has established a network of nine specialized medical clinics across four provinces in Canada to treat patients with chronic pain. Pathway Health's Virtual Clinic division also boasts the largest medical cannabis telemedicine network in Canada.

MySize Inc has announced the partial adjournment of this year's annual stockholder meeting with respect to Proposal 3 outlined in a statement filed with the Securities and Exchange Commission on December 6, 2021. The Airport City, Israel-based creator of innovative measurement solutions, said the meeting was convened for the other proposals which have now been approved and ratified with the requisite majorities. Proposal 3 seeks to amend the company's board into three classes, with members of each class serving three-year terms. “While Proposal 3 has exceeded 95% approval based on votes cast to date, approval of more than 50% of all outstanding shares of the company's common stock as of November 4, 2021, is necessary for the proposal to be approved,” said the firm. MySize said the annual meeting will resume with respect to Proposal 3 at 10.00 am ET on January 6, 2022 at the law offices of Barnea Jaffa Lande & Co. at 58 HaRakevet Street in Tel Aviv. MySize’s measurement solutions are based on its sophisticated patented algorithms with broad applications in the fashion, shipping and parcel package delivery, and Do-It-Yourself industry.

ImagineAR Inc has provided investors with a corporate update for calendar year 2021 as the metaverse becomes a key driver of new business opportunities, positioning the company to deliver global immersive AR mobile engagements for businesses and consumers. "Although sports and live events have been negatively impacted by COVID-19 since last year, ImagineAR made significant progress in advancing our Self-Publishing Platform technology and successfully launching immersive AR campaigns for our global clients," said ImagineAR CEO Alen Paul Silverrstieen in a statement. “We are proud of our revenue growth of 553% from last year and are optimistic that revenue will continue to grow in 2022 as sports venues are opening to fans around the world."

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has provided a recap of its 2021 milestones and highlights as the company expands its portfolio of next-generation psychedelic compounds. In a statement, Mindset CEO James Lanthier called 2021 “just the beginning” for the company. “We are building the industry’s leading drug discovery platform and intend to continue to break new ground in psychedelic drug discovery in order to bring patented, safe and effective therapies to those suffering from a range of mental illnesses and neurological disorders. “In 2021, we made significant progress in building our portfolio of next-generation psychedelic compounds showing improved preclinical safety and efficacy of 5-MeO-DMT and psilocybin-based therapies,” Lanthier said.

Electra Battery Materials Corporation (TSX-V:ELBM, OTCQX:FTSSF) said it has signed a five-year cobalt tolling contract and has amended the previously concluded five-year cobalt hydroxide feed purchase agreement with Glencore PLC (LSE:GLEN). The company has said it intends to produce a traceable, low carbon battery grade cobalt product for the electric vehicle market and the parties will market the Canadian-made cobalt sulfate as a premium brand product that is sustainably mined and refined with renewable hydroelectric power. "Today's announcement is a validation of our strategy by the world's largest cobalt miner," said Trent Mell, Electra Battery Materials CEO in a statement.

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced that its US Food and Drug Administration (FDA) Phase 3 clinical trial study evaluating the safety and efficacy of Bucillamine— an oral drug with anti-inflammatory and antiviral properties — in patients with mild to moderate coronavirus (COVID-19) has screened approximately 700 subjects to date. The company said that it has decided to fill a part of its patient enrollment quota outside of the U.S. and target Eastern Europe, such as Turkey, where the reported cases of COVID-19 are high with 32,176 new COVID-19 infections reported on December 28, 2021. The decision to enroll patients outside the U.S. was made to ensure a diversified patient population to support future global regulatory submissions for Bucillamine, including the FDA, and follows Phase 3 clinical studies and FDA approvals of oral antiviral treatments by Pfizer and Merck. 

Altiplano Metals Inc (TSX-V:APN, OTC:ALTPF) has provided an update on the construction phase at the El Peñón processing facility to support the Farellon Iron-Oxide-Copper-Gold (Cu-Au) mine located near La Serena, Chile. The company reported that the magnetic separator and dewatering equipment have arrived at the El Peñón processing facility. In preparation for the installation, the civil work for the four concrete platforms required to support the construction and integrate the equipment into the final processing circuit has begun. In a statement, Altiplano CEO Alastair McIntyre commented: "The arrival of this important equipment highlights APN's commitment to integrate our production activities with our processing operations while focusing on environmentally friendly methods to leverage our bottom line."

African Gold Group Inc. CEO Danny Callow called 2021 “a transformative” year as the company expects accelerated growth in 2022 and beyond with its Kobada Gold project in Southern Mali. “As we move into 2022, the principal focus of our growth strategy next year is to complete the financing of the project so that we can move into construction phase,” Callow said in a letter to shareholders. “AGG’s team and I would like to thank all of our shareholders for your continued support. None of our progress and the opportunity that lies ahead would be possible without you. The last year has been both a challenging and exciting period for African Gold Group, as we have positioned the company to execute on its ambitious agenda for 2022. I believe 2022 will be a year of significant success for the African Gold Group and, as a result, shareholder value.”

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc said its board of directors has authorized the repurchase by the company of up to 2 million of its subordinate Class B voting shares, being approximately 5% of its issued and outstanding subordinate voting shares, from time to time over the next 12 months. The company said the share repurchase program will allow it to use its excess cash reserves to strategically return value to shareholders. "FSD Pharma (CSE:HUGE, NASDAQ:HUGE) is focused on the advancement of its drug candidates toward the clinic; however, with over USD $39.3 million in cash and cash equivalents on our balance sheet as of September 30, 2021, we recognize there may be a strategic opportunity to enhance shareholder value without compromising our ambitious growth plans,” commented Anthony Durkacz, interim CEO of FSD Pharma (CSE:HUGE, NASDAQ:HUGE) in a statement.

Nabis Holdings Inc has announced the closing of the second and final tranche of a non-brokered private placement for gross proceeds of $155,000. The second and final tranche saw the issuance of 775,000 common shares in the capital of the company at a price of $0.20 per common share. The company said the net proceeds raised from the offering will be used for working capital and general corporate purposes.

MGX Minerals Inc said it has appointed Mo Ahmad of Westmark Tax as its corporate accountant to replace Sandey Wang who has departed as corporate accountant and chief financial officer due to prior commitments. Ahmad has over 17 years of experience as the founder of Westmark Tax. Prior to founding Westmark, he had over 12 years with Ernst & Young and other big four accounting firms. A new CFO is expected to be appointed shortly, MGX said. The company also advised that its auditor SHIM & Associates LLP remains the same.

Great Panther Mining Limited (TSX:GPR, NYSE:GPL) has said it intends to file a defense to three Notices of Infraction that were delivered by the Amapa State Environmental Agency to its Brazilian subsidiary, Mina Tucano Ltda on December 21, 2021. The notices were issued in connection with the agency's investigation of a fish mortality event at Areia and Silvestre Creeks, and its assertion that the incident was caused by a leak in a reclaimed water pipe at the Mina Tucano mine site. Mina Tucano is actively investigating whether there could be any connection between the fish mortality event and the Tucano mine site.  Based on its initial investigation, including independent reports on fish toxicology and water quality received by Mina Tucano on December 28, 2021, the company has prepared a formal defense against the position taken by the agency. The notices impose aggregate fines of 50,000,000 Brazilian reals, payable by January 30, 2022. The company intends to appeal the amount of the fines and timing of any payment in its defense statements.

Ayurcann Holdings has announced the results of voting at its annual general and special meeting of shareholders which was held on December 20, 2021, in Toronto, Ontario. All the resolutions, as described in the company’s management information circular dated November 19, 2021, were approved by the requisite majority of votes cast at the meeting., it added. The company also announced the granting of an aggregate of 785,405 restricted share units (RSU) to certain directors, officers, employees and consultants of the company, under its RSU plan. All RSUs granted vest immediately and the common shares issuable upon redemption will be subject to a four-month and one-day hold period under applicable securities laws.

VanadiumCorp Resource Inc (TSX-V:VRB) said it has received approval from the TSX to resume trading on the TSX Venture Exchange. Effective at the market opening today, December 30, 2021, trading will be reinstated in the securities of the Company, trading under the symbol VRB. Adriaan Bakker, the company's president & CEO, commented: "We would like to thank our shareholders for their support while the Company worked to comply with its reporting requirements. VanadiumCorp is now well-positioned to embark on a new phase of growth through exploration and development of its battery metals properties in the Nord du Quebec region."

Champion Gaming (TSX-V:WAGR) Group Inc said it has granted 2,300,000 restricted share units (RSUs) to certain officers, directors and consultants of the company under the terms of its omnibus equity incentive compensation plan. Each RSU entitles the holder to acquire one common share of the company by delivering an exercise notice in accordance with the plan. The RSU grant follows the guidelines of the plan and are subject to approval by the TSX Venture Exchange.

East Side Games Group (TSX:EAGR, OTCQB:LEMLF) Inc - formerly LEAF Mobile Inc - has announced the filing of a final base shelf prospectus with the securities commissions in each of the provinces of Canada excepting Quebec, with a view to providing the company with greater financial flexibility going forward, but has not entered into any agreements or arrangements to authorize or offer any securities at this time. The Final Shelf Prospectus has been filed further to the preliminary base shelf prospectus, which was previously announced on December 6, 2021.  When made final or effective, the Final Shelf Prospectus will allow the company to undertake offerings of its common shares, warrants, debt securities, subscription receipts and units, or any combination thereof, up to an aggregate total of $200 million from time to time during the 25 month period that the Final Shelf Prospectus remains effective.  The securities may be offered in amounts, at prices and on terms to be determined at the time of sale and, subject to applicable regulations, may include “at the market” transactions, public offerings or strategic investments.  The specific terms of any offering of securities, including the use of proceeds from any offering, will be set forth in one or more prospectus supplement(s) to be filled with applicable securities regulators. “The filing of the Final Shelf Prospectus gives us enhanced flexibility and the ability to move quickly as we continue to assess opportunities while executing on our M&A growth strategy,” said Darcy Taylor, CEO of East Side Games Group.

District Metals Corp said the TSX Venture Exchange has accepted for filing documentation with respect to its brokered private placement announced on November 23, 2021, which will see the issue of 7.2 million shares at a purchase price of 25 cents per share together with 3.6 million share purchase warrants with an exercise price of 35 cents for a two-year period with 38 placees.

OTC Markets Group Inc, the operator of financial markets for over 11,000 US and global securities, has announced that Centaurus Metals Ltd (ASX:CTM), a nickel exploration and development company focused in Brazil, has qualified to trade on the OTCQX Best Market and began trading today, December 30, 2021, under the symbol CTTZF. Joining the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors.  For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. Centaurus Metals managing director, Darren Gordon, commented: "It is great to begin trading on the OTCQX and be joining the North American financial community at a time of unprecedented investment by the US government and industry in electrification and decarbonization.  Central to this theme is the demand for low emission nickel which is exactly what Centaurus can deliver from its very large, low emission, Jaguar Nickel Sulphide Project in northern Brazil which presently has a JORC Mineral Resource of 80.6Mt @ 0.91% Ni for 730,700 tonnes of contained nickel."

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 8 minutes ago